Ziad A Massy
Overview
Explore the profile of Ziad A Massy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
412
Citations
9977
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Henaut L, Candellier A, Huish S, Issa N, Sinha S, Massy Z
Clin Kidney J
. 2025 Mar;
18(Suppl 1):i27-i45.
PMID: 40083956
Valvular calcification, developing either in the mitral or the aortic valve, is highly prevalent in patients suffering from chronic kidney disease (CKD), in whom their presence correlates with higher cardiovascular...
2.
Wagner C, Frey-Wagner I, Ortiz A, Unwin R, Liabeuf S, Suzumoto Y, et al.
Nephrol Dial Transplant
. 2025 Mar;
40(Supplement_2):ii4-ii17.
PMID: 40080091
Cognitive decline is frequently seen in patients with chronic kidney disease (CKD). The causes of cognitive decline in these patients are likely to be multifactorial, including vascular disease, uraemic toxins,...
3.
Simeoni M, Mulholland M, Workeneh B, Capasso A, Hafez G, Liabeuf S, et al.
Nephrol Dial Transplant
. 2025 Mar;
40(Supplement_2):ii54-ii63.
PMID: 40080088
Cancer and kidney diseases (KD) intersect in many ways resulting in worse outcomes. Both conditions are correlated with cognitive impairment, which can be exacerbated in cancer patients by known effects...
4.
5.
Vanholder R, Glorieux G, Argiles A, Burtey S, Cohen G, Duranton F, et al.
Kidney Med
. 2025 Feb;
7(3):100955.
PMID: 39980938
A comprehensive review of known uremic retention molecules goes back to more than 10 years ago and did not consider metabolomic analyses. The present analysis searches for as of yet...
6.
Xu H, Eriksdotter M, Hafez G, Mitra S, Bruchfeld A, Pesic V, et al.
Nephrol Dial Transplant
. 2025 Feb;
PMID: 39919765
Cholinergic synapses are widespread throughout the human central nervous system. Their high density in the thalamus, neocortex, limbic system, and striatum suggests that cholinergic transmission plays a vital role in...
7.
Laville S, Vendar J, Massy Z, Gras-Champel V, Moragny J, Frimat L, et al.
Clin Kidney J
. 2025 Jan;
18(1):sfae357.
PMID: 39781474
Background: We sought to comprehensively describe drug-related components associated with acute kidney injury (AKI) in patients with chronic kidney disease (CKD), describing the incidence of drug-related AKI, the proportion of...
8.
Mouheb A, Lambert O, Alencar De Pinho N, Jacquelinet C, Laville M, Combe C, et al.
J Nephrol
. 2025 Jan;
PMID: 39775518
Background: Hyperuricemia is a hallmark of gout and a suspected risk factor for the progression of chronic kidney disease (CKD). However, the impact of urate-lowering therapy on CKD progression is...
9.
Altunkaynak H, Karaismailoglu E, Massy Z
Toxins (Basel)
. 2024 Dec;
16(12).
PMID: 39728802
The therapeutic benefit of the oral adsorbent drug AST-120 in chronic kidney disease (CKD) is related to an indoxyl sulfate (IS)-lowering action. Diabetes and dyslipidemia might worsen kidney damage in...
10.
Florens N, Aymes E, Gauthier V, Frimat L, Laville M, Bedo D, et al.
Clin Kidney J
. 2024 Dec;
17(12):sfae337.
PMID: 39678250
Background And Hypothesis: Cardiovascular diseases are a leading cause of morbidity and mortality in patients with chronic kidney disease (CKD). Acute kidney injury (AKI) has been increasingly recognized as a...